348 related articles for article (PubMed ID: 22152414)
1. [Mesalazine and sulphasalazine for Crohn's disease: few indications, severe adverse reactions].
Uittenbogaart SB; Klemt-Kropp M
Ned Tijdschr Geneeskd; 2011; 155(48):A3842. PubMed ID: 22152414
[TBL] [Abstract][Full Text] [Related]
2. [Acute pancreatitis--adverse effect of 5-aminosalicylic acid (mesalazine) in various galenic dosage forms].
Schwörer H; Ramadori G
Dtsch Med Wochenschr; 2000 Nov; 125(44):1328-30. PubMed ID: 11109415
[TBL] [Abstract][Full Text] [Related]
3. [Pancreatitis in a patient with Crohn disease treated with mesalazine and azathioprine].
Glintborg B
Ugeskr Laeger; 2000 Aug; 162(34):4553-4. PubMed ID: 10981226
[TBL] [Abstract][Full Text] [Related]
4. Pancreatitis in inflammatory bowel diseases.
Pitchumoni CS; Rubin A; Das K
J Clin Gastroenterol; 2010 Apr; 44(4):246-53. PubMed ID: 20087199
[TBL] [Abstract][Full Text] [Related]
5. Budesonide and mesalazine in active Crohn's disease: a comparison of the effects on quality of life.
Thomsen OO; Cortot A; Jewell D; Wright JP; Winter T; Veloso FT; Vatn M; Persson T; Pettersson E;
Am J Gastroenterol; 2002 Mar; 97(3):649-53. PubMed ID: 11922560
[TBL] [Abstract][Full Text] [Related]
6. [Pancreatitis associated with 5-aminosalicylic acid].
Eckardt VF; Kanzler G; Rieder H; Ewe K
Dtsch Med Wochenschr; 1991 Apr; 116(14):540-2. PubMed ID: 1707359
[TBL] [Abstract][Full Text] [Related]
7. Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine.
Nakajima H; Munakata A; Yoshida Y
J Gastroenterol; 1995 Nov; 30 Suppl 8():115-7. PubMed ID: 8563870
[TBL] [Abstract][Full Text] [Related]
8. A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group.
Thomsen OO; Cortot A; Jewell D; Wright JP; Winter T; Veloso FT; Vatn M; Persson T; Pettersson E
N Engl J Med; 1998 Aug; 339(6):370-4. PubMed ID: 9691103
[TBL] [Abstract][Full Text] [Related]
9. Mesalazine-associated tubulo-interstitial nephritis in inflammatory bowel disease.
Calviño J; Romero R; Pintos E; Losada E; Novoa D; Güimil D; Mardaras J; Sanchez-Guisande D
Clin Nephrol; 1998 Apr; 49(4):265-7. PubMed ID: 9582560
[TBL] [Abstract][Full Text] [Related]
10. [Acute pancreatitis induced by drugs derived from 5-aminosalicylic acid: case report and review of the literature].
Decocq G; Gras-Champel V; Vrolant-Mille C; Delcenserie R; Sauvé L; Masson H; Andréjak M
Therapie; 1999; 54(1):41-8. PubMed ID: 10216421
[TBL] [Abstract][Full Text] [Related]
11. [Mesalazine-related interstitial lung disease: an under-diagnosed effect?].
Auffret M; Béné J; Lambert M; Gautier S
Therapie; 2014; 69(6):531-2. PubMed ID: 25320942
[TBL] [Abstract][Full Text] [Related]
12. [Mesalazine-induced eosinophilic pneumonia in a patient with Crohn's disease].
Park JE; Hwangbo Y; Chang R; Chang YW; Jang JY; Kim BH; Dong SH; Kim HJ
Korean J Gastroenterol; 2009 Feb; 53(2):116-20. PubMed ID: 19237838
[TBL] [Abstract][Full Text] [Related]
13. Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial.
Reinisch W; Angelberger S; Petritsch W; Shonova O; Lukas M; Bar-Meir S; Teml A; Schaeffeler E; Schwab M; Dilger K; Greinwald R; Mueller R; Stange EF; Herrlinger KR;
Gut; 2010 Jun; 59(6):752-9. PubMed ID: 20551460
[TBL] [Abstract][Full Text] [Related]
14. [Interstitial pneumonia related to mesalamine].
Lamsiah T; Moudden K; Baaj M; Hadri L
Gastroenterol Clin Biol; 2010 Mar; 34(3):224-6. PubMed ID: 20299168
[TBL] [Abstract][Full Text] [Related]
15. Sulfasalazine and mesalazine for the maintenance therapy of Crohn's disease: a meta-analysis.
Steinhart AH; Hemphill D; Greenberg GR
Am J Gastroenterol; 1994 Dec; 89(12):2116-24. PubMed ID: 7977225
[TBL] [Abstract][Full Text] [Related]
16. Drug insight: aminosalicylates for the treatment of IBD.
Nielsen OH; Munck LK
Nat Clin Pract Gastroenterol Hepatol; 2007 Mar; 4(3):160-70. PubMed ID: 17339853
[TBL] [Abstract][Full Text] [Related]
17. [Tubulo-interstitial nephritis in inflammatory bowel disease: extra-intestinal manifestation or drug toxicity?].
Heidt J; Ooms EC; van der Werf SD; Groeneveld JH
Ned Tijdschr Geneeskd; 2010; 154():A1647. PubMed ID: 20699041
[TBL] [Abstract][Full Text] [Related]
18. Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines.
Ransford RA; Langman MJ
Gut; 2002 Oct; 51(4):536-9. PubMed ID: 12235076
[TBL] [Abstract][Full Text] [Related]
19. [Diffuse alopecia as side effect of mesalazine therapy in Crohn's disease].
Netzer P
Schweiz Med Wochenschr; 1995 Dec; 125(50):2438-42. PubMed ID: 8553032
[TBL] [Abstract][Full Text] [Related]
20. A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID).
Colombel JF; Lémann M; Cassagnou M; Bouhnik Y; Duclos B; Dupas JL; Notteghem B; Mary JY
Am J Gastroenterol; 1999 Mar; 94(3):674-8. PubMed ID: 10086650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
